JBT Marel Corp risk profile
38 Normal where most of the sector sits
Measured 21 October 2026 from JBTM's filed statements. Recomputed nightly.
38 (Normal), driven by Leverage and coverage at 57, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 52 | Elevated | Stable | Drawdown from the 52-week high — 38.0% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 37 | Normal | Worsening | Capital spending against operating cash — 0.30x |
| Leverage and coverage | 57 | Elevated | Worsening | Net debt to EBITDA — 3.76x |
| Competitive position | 38 | Normal | Stable | Operating-margin gap against peers — -4.8 percentage points |
| Concentration | 25 | Normal | Stable | Geographic concentration — 1,435 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.